Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
TerrAscend participates in a conference call hosted by Craig Hallum » 09:16
08/04/20
08/04
09:16
08/04/20
09:16
TRSSF

TerrAscend

$0.00 /

+ (+0.00%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRSSF TerrAscend
$0.00 /

+ (+0.00%)

TRSSF TerrAscend
$0.00 /

+ (+0.00%)

07/22/20 Stifel
TerrAscend re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/15/20 Ladenburg
TerrAscend initiated with a Buy at Ladenburg
06/08/20 Craig-Hallum
TerrAscend initiated with a Buy at Craig-Hallum
Thursday
On The Fly
Rising High: Cure to acquire Sera Labs as Biome Grow sells subsidiary » 11:11
07/30/20
07/30
11:11
07/30/20
11:11
CURR

CURE Pharmaceutical

$0.00 /

+ (+0.00%)

, MYMMF

MYM Nutraceuticals

$0.00 /

+ (+0.00%)

, BIOIF

Biome Grow

$0.00 /

+ (+0.00%)

, APHA

Aphria

$4.88 /

-0.005 (-0.10%)

, IIPR

Innovative Industrial Properties

$103.89 /

-0.13 (-0.12%)

, GNLN

Greenlane

$3.93 /

+0.09 (+2.34%)

, CROX

Crocs

$38.24 /

+1 (+2.69%)

, ACB

Aurora Cannabis

$10.48 /

-0.205 (-1.92%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CGC

Canopy Growth

$18.18 /

-0.31 (-1.68%)

, CRON

Cronos Group

$6.52 /

-0.225 (-3.34%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, IGC

India Globalization Capital

$0.60 /

-0.0065 (-1.07%)

, TLRY

Tilray

$7.41 /

-0.125 (-1.66%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$3.62 /

-0.15 (-3.98%)

In this week's "Rising…

Open Full Text

ShowHide Related Items >><<
ZYNE Zynerba
$3.62 /

-0.15 (-3.98%)

TLRY Tilray
$7.41 /

-0.125 (-1.66%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

IIPR Innovative Industrial Properties
$103.89 /

-0.13 (-0.12%)

IGC India Globalization Capital
$0.60 /

-0.0065 (-1.07%)

GNLN Greenlane
$3.93 /

+0.09 (+2.34%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CURR CURE Pharmaceutical
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CROX Crocs
$38.24 /

+1 (+2.69%)

CRON Cronos Group
$6.52 /

-0.225 (-3.34%)

CGC Canopy Growth
$18.18 /

-0.31 (-1.68%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

BIOIF Biome Grow
$0.00 /

+ (+0.00%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

ACB Aurora Cannabis
$10.48 /

-0.205 (-1.92%)

CURR CURE Pharmaceutical
$0.00 /

+ (+0.00%)

MYMMF MYM Nutraceuticals
$0.00 /

+ (+0.00%)

BIOIF Biome Grow
$0.00 /

+ (+0.00%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

07/30/20 CIBC
Aphria price target raised to C$7.50 from C$6 at CIBC
07/16/20 Cantor Fitzgerald
Aphria price target raised to C$10.50 from C$9.55 at Cantor Fitzgerald
07/15/20 Alliance Global Partners
Aphria better served staying 'nimble' right now, says Alliance Global Partners
07/15/20 Scotiabank
Aurora Cannabis, Aphria merger would make sense, says Scotiabank
IIPR Innovative Industrial Properties
$103.89 /

-0.13 (-0.12%)

07/28/20 JMP Securities
Innovative Industrial Properties initiated with an Outperform at JMP Securities
07/06/20 Roth Capital
Innovative Industrial Properties price target raised to $120 from $110 at Roth Capital
06/23/20 Ladenburg
Innovative Industrial Properties price target raised to $104 from $83.50 at Ladenburg
05/21/20 Compass Point
Innovative Industrial price target raised to $100 from $75 at Compass Point
GNLN Greenlane
$3.93 /

+0.09 (+2.34%)

03/31/20 Roth Capital
Greenlane price target lowered to $4 from $9 at Roth Capital
10/07/19 Roth Capital
Greenlane price target lowered to $10 from $18.50 at Roth Capital
CROX Crocs
$38.24 /

+1 (+2.69%)

07/27/20 Pivotal Research
Crocs price target raised to $41 from $29 at Pivotal Research
07/22/20 UBS
Crocs initiated with a Neutral at UBS
07/17/20
Fly Intel: Top five analyst downgrades
07/17/20 CL King
Crocs downgraded to Neutral on valuation at CL King
ACB Aurora Cannabis
$10.48 /

-0.205 (-1.92%)

07/15/20 Stifel
Aurora, Aphria merger could still come to fruition, says Stifel
06/24/20
Fly Intel: Top five analyst upgrades
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
03/17/20 Roth Capital
CV Sciences downgraded to Neutral from Buy at Roth Capital
CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$18.18 /

-0.31 (-1.68%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
CRON Cronos Group
$6.52 /

-0.225 (-3.34%)

06/24/20 Raymond James
Cronos Group upgraded to Outperform from Market Perform at Raymond James
04/27/20 Raymond James
Cronos Group downgraded to Market Perform from Outperform at Raymond James
04/14/20 Piper Sandler
Piper Sandler downgrades Cronos to Neutral on delayed CBD launch
CANN General Cannabis
$0.00 /

+ (+0.00%)

11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
IGC India Globalization Capital
$0.60 /

-0.0065 (-1.07%)

TLRY Tilray
$7.41 /

-0.125 (-1.66%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Trulieve Cannabis re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/22/20 AltaCorp
Trulieve Cannabis initiated with an Outperform at AltaCorp
ZYNE Zynerba
$3.62 /

-0.15 (-3.98%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$3.62 /

-0.15 (-3.98%)

TLRY Tilray
$7.41 /

-0.125 (-1.66%)

IIPR Innovative Industrial Properties
$103.89 /

-0.13 (-0.12%)

GNLN Greenlane
$3.93 /

+0.09 (+2.34%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CROX Crocs
$38.24 /

+1 (+2.69%)

CRON Cronos Group
$6.52 /

-0.225 (-3.34%)

CGC Canopy Growth
$18.18 /

-0.31 (-1.68%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

ACB Aurora Cannabis
$10.48 /

-0.205 (-1.92%)

  • 30
    Jun
  • 27
    May
  • 24
    Jan
  • 31
    Oct
CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$18.18 /

-0.31 (-1.68%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

IIPR Innovative Industrial Properties
$103.89 /

-0.13 (-0.12%)

GNLN Greenlane
$3.93 /

+0.09 (+2.34%)

CURR CURE Pharmaceutical
$0.00 /

+ (+0.00%)

CROX Crocs
$38.24 /

+1 (+2.69%)

BIOIF Biome Grow
$0.00 /

+ (+0.00%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

ZYNE Zynerba
$3.62 /

-0.15 (-3.98%)

TLRY Tilray
$7.41 /

-0.125 (-1.66%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CROX Crocs
$38.24 /

+1 (+2.69%)

CRON Cronos Group
$6.52 /

-0.225 (-3.34%)

CGC Canopy Growth
$18.18 /

-0.31 (-1.68%)

APHA Aphria
$4.88 /

-0.005 (-0.10%)

ACB Aurora Cannabis
$10.48 /

-0.205 (-1.92%)

Over a week ago
On The Fly
Rising High: An exclusive talk with holding company Cann American Corp. » 11:16
07/23/20
07/23
11:16
07/23/20
11:16
CNNA

Cann American Corp.

$0.00 /

+ (+0.00%)

, APHA

Aphria

$5.11 /

-0.045 (-0.87%)

, ACB

Aurora Cannabis

$10.82 /

-0.35 (-3.13%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CGC

Canopy Growth

$16.92 /

-0.385 (-2.22%)

, CRON

Cronos Group

$6.50 /

-0.145 (-2.18%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, IGC

India Globalization Capital

$0.55 /

-0.01 (-1.79%)

, TLRY

Tilray

$7.21 /

-0.03 (-0.41%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$3.66 /

-0.09 (-2.40%)

In this edition of…

Open Full Text

ShowHide Related Items >><<
ZYNE Zynerba
$3.66 /

-0.09 (-2.40%)

TLRY Tilray
$7.21 /

-0.03 (-0.41%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

IGC India Globalization Capital
$0.55 /

-0.01 (-1.79%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.50 /

-0.145 (-2.18%)

CGC Canopy Growth
$16.92 /

-0.385 (-2.22%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

ACB Aurora Cannabis
$10.82 /

-0.35 (-3.13%)

CNNA Cann American Corp.
$0.00 /

+ (+0.00%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

07/16/20 Cantor Fitzgerald
Aphria price target raised to C$10.50 from C$9.55 at Cantor Fitzgerald
07/15/20 Alliance Global Partners
Aphria better served staying 'nimble' right now, says Alliance Global Partners
07/15/20 Scotiabank
Aurora Cannabis, Aphria merger would make sense, says Scotiabank
07/15/20 Stifel
Aurora, Aphria merger could still come to fruition, says Stifel
ACB Aurora Cannabis
$10.82 /

-0.35 (-3.13%)

06/24/20
Fly Intel: Top five analyst upgrades
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
03/17/20 Roth Capital
CV Sciences downgraded to Neutral from Buy at Roth Capital
CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$16.92 /

-0.385 (-2.22%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
CRON Cronos Group
$6.50 /

-0.145 (-2.18%)

06/24/20 Raymond James
Cronos Group upgraded to Outperform from Market Perform at Raymond James
04/27/20 Raymond James
Cronos Group downgraded to Market Perform from Outperform at Raymond James
04/14/20 Piper Sandler
Piper Sandler downgrades Cronos to Neutral on delayed CBD launch
CANN General Cannabis
$0.00 /

+ (+0.00%)

11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
IGC India Globalization Capital
$0.55 /

-0.01 (-1.79%)

TLRY Tilray
$7.21 /

-0.03 (-0.41%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Trulieve Cannabis re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/22/20 AltaCorp
Trulieve Cannabis initiated with an Outperform at AltaCorp
ZYNE Zynerba
$3.66 /

-0.09 (-2.40%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$3.66 /

-0.09 (-2.40%)

TLRY Tilray
$7.21 /

-0.03 (-0.41%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CRON Cronos Group
$6.50 /

-0.145 (-2.18%)

CGC Canopy Growth
$16.92 /

-0.385 (-2.22%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

ACB Aurora Cannabis
$10.82 /

-0.35 (-3.13%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$16.92 /

-0.385 (-2.22%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CNNA Cann American Corp.
$0.00 /

+ (+0.00%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

TLRY Tilray
$7.21 /

-0.03 (-0.41%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.50 /

-0.145 (-2.18%)

CGC Canopy Growth
$16.92 /

-0.385 (-2.22%)

APHA Aphria
$5.11 /

-0.045 (-0.87%)

ACB Aurora Cannabis
$10.82 /

-0.35 (-3.13%)

Recommendations
Curaleaf Holdings price target raised to C$14 from C$12 at Alliance Global Partners » 10:57
07/23/20
07/23
10:57
07/23/20
10:57
CURLF

Curaleaf Holdings

$0.00 /

+ (+0.00%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey raised the firm's price target on Curaleaf Holdings to C$14 from C$12 and keeps a Buy rating on the shares after the company announced the closing of its Grassroots acquisition. The closing of the deal, which he has previously highlighted as a catalyst, gives the company new or deeper exposure in several key states, said Grey.

ShowHide Related Items >><<
CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Curaleaf Holdings re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/22/20 Alliance Global Partners
Alliance Global says amended terms for Grassroots deal a positive for Curaleaf
06/08/20 Roth Capital
Curaleaf Holdings initiated with a Buy at Roth Capital
CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

Hot Stocks
Curaleaf Holdings completes acquisition of Grassroots » 10:54
07/23/20
07/23
10:54
07/23/20
10:54
CURLF

Curaleaf Holdings

$0.00 /

+ (+0.00%)

Curaleaf Holdings…

Curaleaf Holdings announced earlier this morning that it closed its "milestone" acquisition of GR Companies, or "Grassroots," which it identifies as the largest private vertically-integrated multi-state operator in the United States, on July 23. "With completion of the acquisition of Grassroots, Curaleaf is the world's largest cannabis company by revenue and the most diversified vertically integrated cannabis company in the United States, the world's largest cannabis market. The transaction expands Curaleaf's presence from 18 to 23 states, with the combined company having affiliated operations spanning over 135 dispensary licenses, 88 operational dispensary locations, over 30 processing facilities and 22 cultivation sites with 1.6 million square feet of current cultivation capacity. Curaleaf's expanded geographic dispensary presence now offers access to medical or adult use Cannabis to more than 192 million people, or roughly two-thirds of the United States population... Completion of the transaction strategically accelerates Curaleaf's expansion into Illinois and Pennsylvania, which are among the largest and fastest-growing cannabis markets in the United States. Upon close, Curaleaf will hold a leading licensed cannabis presence in state markets including Arizona, Connecticut, Florida, Illinois, Pennsylvania, Maryland, Massachusetts, Maine, Nevada, New Jersey, New York, North Dakota, and Vermont," the company stated.

ShowHide Related Items >><<
CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Curaleaf Holdings re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/22/20 Alliance Global Partners
Alliance Global says amended terms for Grassroots deal a positive for Curaleaf
06/08/20 Roth Capital
Curaleaf Holdings initiated with a Buy at Roth Capital
CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

Initiation
Pharmacielo re-initiated with a Speculative Buy at Stifel » 07:38
07/22/20
07/22
07:38
07/22/20
07:38
PCLOF

Pharmacielo

$0.00 /

+ (+0.00%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou re-initiated coverage of Pharmacielo with a Speculative Buy rating and C$4 price target. The analyst views the company as a "potential pioneer" of the intercontinental CBD supply chain. CBD is a commoditized ingredient where the near-term winner could be the company that produces high quality inputs at the lowest cost, Partheniou tells investors in a research note.

ShowHide Related Items >><<
PCLOF Pharmacielo
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
Initiation
Harvest Health & Recreation re-initiated with a Hold at Stifel » 07:37
07/22/20
07/22
07:37
07/22/20
07:37
HRVSF

Harvest Health & Recreation

$0.00 /

+ (+0.00%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou re-initiated coverage of Harvest Health & Recreation with a Hold rating and C$1.50 price target. While Harvest has historically been one of the more aggressive MSOs and sought to grow its platform through a series of acquisitions, management has had difficulty completing larger deals, the analyst noted. The company has now shifted its priorities towards achieving profitability and a reorientation towards core states following a management shakeup, the analyst added.

ShowHide Related Items >><<
HRVSF Harvest Health & Recreation
$0.00 /

+ (+0.00%)

HRVSF Harvest Health & Recreation
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
05/21/20 Canaccord
Canaccord keeps Speculative Buy rating on Harvest Health following Q1 results
05/21/20 Alliance Global Partners
Harvest Health price target raised to C$2.30 from C$1.40 at Alliance Global
03/27/20 Canaccord
Harvest Health & Recreation price target lowered to C$4.50 from C$7 at Canaccord
Initiation
TerrAscend re-initiated with a Buy at Stifel » 07:37
07/22/20
07/22
07:37
07/22/20
07:37
TRSSF

TerrAscend

$0.00 /

+ (+0.00%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou re-initiated coverage of TerrAscend with a Buy rating and C$4.75 price target. The company's recently appointed CEO, Jason Ackerman, has applied a "focused approach and strong cost control to rapidly generate profitability" within his first full quarter at the helm, Partheniou tells investors in a research note.

ShowHide Related Items >><<
TRSSF TerrAscend
$0.00 /

+ (+0.00%)

TRSSF TerrAscend
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/15/20 Ladenburg
TerrAscend initiated with a Buy at Ladenburg
06/08/20 Craig-Hallum
TerrAscend initiated with a Buy at Craig-Hallum
Initiation
Cresco Labs re-initiated with a Buy at Stifel » 07:36
07/22/20
07/22
07:36
07/22/20
07:36
CRLBF

Cresco Labs

$0.00 /

+ (+0.00%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou re-initiated coverage of Cresco Labs with a Buy rating and C$10 price target. The analyst believes the company's growth story is in the "early innings," says it has yet to benefit from investments made in expanding its brand and distribution presence.

ShowHide Related Items >><<
CRLBF Cresco Labs
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
06/12/20 Needham
Cresco Labs initiated with a Hold at Needham
04/28/20 Canaccord
Cresco Labs price target lowered to C$11.50 from C$12.50 at Canaccord
03/30/20 Cantor Fitzgerald
Cresco Labs price target lowered to $10 from $12 at Cantor Fitzgerald
CRLBF Cresco Labs
$0.00 /

+ (+0.00%)

Initiation
Supreme Cannabis re-initiated with a Hold at Stifel » 07:35
07/22/20
07/22
07:35
07/22/20
07:35
SPRWF

Supreme Cannabis

$0.00 /

+ (+0.00%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou re-initiated coverage of Supreme Cannabis with a Hold rating and C$0.30 price target. He is taking a "cautioned stance" as Supreme has recently gone through a management shakeup, which has the potential to change its identity, the analyst tells investors. Supreme has built solid brand recognition through its flower products, which are high-quality with premium pricing, but has begun an initiative to move down the pricing scale, the analyst said.

ShowHide Related Items >><<
SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
05/19/20 Stifel
Supreme Cannabis price target lowered to C$0.30 from C$0.50 at Stifel
05/19/20 CIBC
Supreme Cannabis price target lowered to C$0.35 from C$0.50 at CIBC
01/07/20 CIBC
Supreme Cannabis downgraded to Neutral from Outperformer at CIBC
SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.